Skip to main content
. 2022 Nov 20;23(22):14427. doi: 10.3390/ijms232214427

Figure 4.

Figure 4

(A) The treatment of CS-Arg/TCEP nanogels for asthma. (B) TEM images of mucin and mixtures of mucin with different samples. (C) Antibacterial experiments of CS-Arg/TCEP nanogels. Reproduced with permission from (1) 1 h and (2) 24 h pictures of the inhibition of different samples against S. aureus aureus. (3) Quantitative of (1-2). (4) 1 h and (5) 24 h pictures of the inhibition of different samples against E. coli aureus. (6) Quantitative of (4-5). Statistics: ** p < 0.01, and *** p < 0.001. [38], Copyright © 2022 American Chemical Society.